Login to Your Account

Vivus' Offering Raises $21M For Sexual Dysfunction Trials

By Jennifer Boggs

Friday, March 11, 2005
Vivus Inc. is raising $21.25 million in a public offering to fund clinical trials for four product candidates in sexual dysfunction. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription